| Market Cap | ₹23,204Cr |
| ROE | 15.17% |
| P/E Ratio(TTM) | 28.69 |
| EPS(TTM) | 176.76 |
| P/B Ratio | 5.50 |
| Dividend Yield | 3.25% |
| Industry P/E | 39.62 |
| Book Value | 921.88 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
| Parent Organisation | Pfizer Limited |
| Managing Director | Mrs. Meenakshi Nevatia |
| NSE Symbol | PFIZER |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 40.56 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 45.94 | ||
| Astrazeneca Pharma India | NA (0.00%) | 123.79 | ||
| Sanofi Consumer Healthcare India | NA (0.00%) | 53.48 |